These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26780523)

  • 1. The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy.
    James LK
    Curr Allergy Asthma Rep; 2016 Feb; 16(2):15. PubMed ID: 26780523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Multifaceted B Cell Response in Allergen Immunotherapy.
    Jiménez-Saiz R; Patil SU
    Curr Allergy Asthma Rep; 2018 Oct; 18(12):66. PubMed ID: 30291463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen immunotherapy: a history of the first 100 years.
    Fitzhugh DJ; Lockey RF
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):554-9. PubMed ID: 21971334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts.
    Wisniewski J; Agrawal R; Woodfolk JA
    Clin Exp Allergy; 2013 Feb; 43(2):164-76. PubMed ID: 23331558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
    van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
    Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapy.
    Levin M; King JJ; Glanville J; Jackson KJ; Looney TJ; Hoh RA; Mari A; Andersson M; Greiff L; Fire AZ; Boyd SD; Ohlin M
    J Allergy Clin Immunol; 2016 May; 137(5):1535-44. PubMed ID: 26559321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological mechanisms of allergen-specific immunotherapy].
    Allam JP; Novak N
    Hautarzt; 2017 Apr; 68(4):265-270. PubMed ID: 28299382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of immune responses by immunotherapy in allergic diseases.
    Cavkaytar O; Akdis CA; Akdis M
    Curr Opin Pharmacol; 2014 Aug; 17():30-7. PubMed ID: 25062122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.
    Palomares O; Akdis M; Martín-Fontecha M; Akdis CA
    Immunol Rev; 2017 Jul; 278(1):219-236. PubMed ID: 28658547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.
    Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA
    Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers.
    Boonpiyathad T; Meyer N; Moniuszko M; Sokolowska M; Eljaszewicz A; Wirz OF; Tomasiak-Lozowska MM; Bodzenta-Lukaszyk A; Ruxrungtham K; van de Veen W
    Allergy; 2017 Mar; 72(3):407-415. PubMed ID: 27341567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK; Francis JN; Durham SR
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-specific immunotherapy: is it vaccination against toxins after all?
    Bachmann MF; Kündig TM
    Allergy; 2017 Jan; 72(1):13-23. PubMed ID: 27558586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of allergen-specific immunotherapy.
    Akdis CA; Akdis M
    J Allergy Clin Immunol; 2011 Jan; 127(1):18-27; quiz 28-9. PubMed ID: 21211639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of allergen-specific desensitization.
    Uermösi C; Beerli RR; Bauer M; Manolova V; Dietmeier K; Buser RB; Kündig TM; Saudan P; Bachmann MF
    J Allergy Clin Immunol; 2010 Aug; 126(2):375-83. PubMed ID: 20624641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renaissance of the blocking antibody concept in type I allergy.
    Flicker S; Valenta R
    Int Arch Allergy Immunol; 2003 Sep; 132(1):13-24. PubMed ID: 14555854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory cells in allergen-specific immunotherapy.
    Soyka MB; Holzmann D; Akdis CA
    Immunotherapy; 2012 Apr; 4(4):389-96. PubMed ID: 22512633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.